BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Vrije Universiteit Amsterdam//NONSGML v1.0//EN
NAME:Inaugural lecture prof.dr. K.H.N. de Boer
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART:20260109T154500
DTEND:20260109T171500
DTSTAMP:20260109T154500
UID:2026/inaugural-lecture-prof-dr@8F96275E-9F55-4B3F-A143-836282E12573
CREATED:20260414T235325
LOCATION:Hoofdgebouw, Aula De Boelelaan 
 1105 1081 HV  Amsterdam
SUMMARY:Inaugural lecture prof.dr. K.H.N. de Boer
X-ALT-DESC;FMTTYPE=text/html: <html> <body> <p>Amazing drug discoverie
 s: het onderste uit de kan</p> <p>To provide affordable and high-qual
 ity care to patients with inflammatory bowel disease (IBD), both in t
 he Netherlands and abroad, now and in the future, we must approach th
 is care from an efficiency perspective. Only then will costs and envi
 ronmental impact become integral factors in the choice of a specific 
 medication. And once a well-balanced medication choice has been made,
  treatment must be optimized to maximize its potential. This is what 
 gastroenterologist Nanne de Boer says in his inaugural lecture.</p><p
 >"At the same time, we must focus on expanding the treatment arsenal,
  because unfortunately, medications don't work for everyone. We need 
 to embrace drug rediscovery - the practice of giving a medication for
  a completely different indication - more as this is a cost-effective
  and rapid method for new medication development," says De Boer.</p> 
 </body> </html>
DESCRIPTION: To provide affordable and high-quality care to patients w
 ith inflammatory bowel disease (IBD), both in the Netherlands and abr
 oad, now and in the future, we must approach this care from an effici
 ency perspective. Only then will costs and environmental impact becom
 e integral factors in the choice of a specific medication. And once a
  well-balanced medication choice has been made, treatment must be opt
 imized to maximize its potential. This is what gastroenterologist Nan
 ne de Boer says in his inaugural lecture. "At the same time, we must 
 focus on expanding the treatment arsenal, because unfortunately, medi
 cations don't work for everyone. We need to embrace drug rediscovery 
 - the practice of giving a medication for a completely different indi
 cation - more as this is a cost-effective and rapid method for new me
 dication development," says De Boer. Amazing drug discoveries: het on
 derste uit de kan
END:VEVENT
END:VCALENDAR
